METASTAIN

Serial Number 76217110
606

Registration Progress

Application Filed
Feb 27, 2001
Under Examination
Apr 6, 2004
Approved for Publication
Dec 4, 2002
Published for Opposition
Dec 24, 2002
Registered

Trademark Image

METASTAIN

Basic Information

Serial Number
76217110
Filing Date
February 27, 2001
Published for Opposition
December 24, 2002
Abandonment Date
October 7, 2004
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 7, 2004
Classes
005

Rights Holder

Biostratum, Inc.

03
Address
4825 Creekstone Drive, Suite 200
Durham, NC 27703

Ownership History

Biostratum, Inc.

Original Applicant
03
Durham, NC

Biostratum, Inc.

Owner at Publication
03
Durham, NC

Legal Representation

Attorney
David S Harper

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

12 events
Date Code Type Description Documents
Feb 2, 2005 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 2, 2005 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jun 23, 2004 CFIT O CASE FILE IN TICRS Loading...
Apr 6, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 4, 2003 MAIL I PAPER RECEIVED Loading...
Dec 24, 2002 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2002 NPUB O NOTICE OF PUBLICATION Loading...
Sep 27, 2002 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 24, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 13, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 6, 2001 CNRT F NON-FINAL ACTION MAILED Loading...
Jun 26, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Reagents, antibodies, diagnostic preparations, other chemicals, and kits comprised of reagents, antibodies, diagnostic preparations, and other chemicals for use in medical science, particularly in the field of cancer diagnosis and therapeutics; therapeutic preparations for use in medical science, particularly in the field of cancer diagnosis and therapeutics
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005